Analyst Viewpoint
Rise in prevalence of gastrointestinal infections is driving the global market. Gastrointestinal pathogens pose a substantial public health burden across the globe. Increase in need for advanced testing methods to detect and identify various pathogens responsible for gastrointestinal diseases is propelling market expansion. Furthermore, surge in demand for point-of-care (POC) testing is expected bolster the global gastrointestinal pathogen testing market size during the forecast period.
Focus on extensive research and development to expand existing clinical diagnostic applications offers lucrative opportunities to market players. Companies are focusing on enhancing diagnostic accuracy, reduce turnaround times, and improve overall efficiency in clinical laboratories in order to increase revenue.
However, high cost associated with advanced diagnostic technologies, need for skilled personnel, and regulatory hurdles are expected to restrain the global gastrointestinal pathogen testing market.
Gastrointestinal (GI) pathogen testing is a diagnostic approach used to identify the specific microorganisms causing a gastrointestinal (GI) infection. These infections can be caused by various pathogens, including bacteria, viruses, and parasites, each with its own unique characteristics and treatment options.
Accurate diagnosis through GI pathogen testing is crucial for implementing effective treatment and preventing further spread of the infection. This type of testing is often recommended when individuals present with symptoms such as diarrhea, abdominal pain, nausea, vomiting, and fever. In healthcare settings, gastrointestinal pathogen testing is crucial for diagnosing and managing infectious gastroenteritis, food poisoning, and other gastrointestinal infections.
Advances in technology have led to the development of multiplex panels that allow simultaneous detection of multiple pathogens in a single test. These panels enhance the efficiency of diagnosis by providing comprehensive results in a shorter time frame. They are especially beneficial in cases where multiple pathogens could be responsible for the symptoms.
The testing process also aids in monitoring antimicrobial resistance patterns among gastrointestinal pathogens. Understanding the resistance profiles of these microorganisms is vital for guiding appropriate antibiotic therapy and addressing the global concern of antimicrobial resistance.
Surge in gastrointestinal disorders is fueling the global gastrointestinal pathogen testing market growth. Various gastrointestinal issues such as infections, inflammations, functional disorders, and cancers have been rising globally due to changing lifestyles, dietary changes, environmental influences, and an aging population.
Bacterial, viral, and parasitic infections contribute to acute conditions such as diarrhea, food poisoning, and gastroenteritis, thus driving the need for effective pathogen testing methods.
Chronic conditions such as inflammatory bowel disease (IBD), Crohn's disease, ulcerative colitis, and colorectal cancer pose significant health risks. The need for precise and early diagnosis of these disorders drives demand for accurate and efficient diagnostic tools capable of identifying specific pathogens responsible for these ailments.
According to the World Health Organization (WHO), digestive diseases are responsible for 700,000 deaths annually, making them the third leading cause of death across the world. The WHO also reports that one in five people globally experience digestive problems each year. A 2022 study published in The Lancet estimated that the global burden of digestive diseases will increase by 35% by 2040, driven by population growth and aging.
This escalation in gastrointestinal disorders has prompted increased emphasis on the development and adoption of advanced testing methods, including molecular diagnostics, point-of-care testing, and non-invasive diagnostic techniques. This, in turn, is expected to propel the global gastrointestinal pathogen testing market demand.
POC testing offers rapid and accurate diagnosis at the patient's bedside or in outpatient settings, enabling immediate initiation of treatment. In the realm of gastrointestinal disorders, quick and precise identification of pathogens causing infections or illnesses such as diarrhea, gastroenteritis, and other digestive tract disorders is crucial for timely intervention.
The convenience and speed offered by POC tests, providing real-time results without the need for centralized laboratory infrastructure, are particularly advantageous in remote or resource-limited settings where immediate diagnosis and treatment decisions are imperative.
These tests often utilize innovative technologies such as molecular assays, immunoassays, or microfluidics, allowing for efficient detection of a broad spectrum of gastrointestinal pathogens.
Thus, surge in adoption of POC testing, driven by portability, ease of use, and accuracy, is propelling the gastrointestinal pathogen testing market revenue.
In terms of test type, the molecular tests segment is projected to dominate the global gastrointestinal pathogen testing industry during the forecast period.
Molecular tests are known for their high sensitivity and specificity, allowing for accurate detection of nucleic acids specific to pathogens. The ability to detect low levels of genetic material contributes to early and precise diagnosis, even in cases with low pathogen concentrations.
Molecular tests can be designed to detect multiple pathogens simultaneously in a single assay. This capability is particularly valuable in diagnosing gastrointestinal infections where various pathogens, including bacteria, viruses, and parasites, may be responsible for similar clinical symptoms.
Technological advancements and new product launch are likely to drive the molecular tests segment during the forecast period. For instance, in April 2023, Molecular Designs, a developer and manufacturer of molecular infectious disease assays, announced the release of its new Simplicity Gastrointestinal Pathogen Panel for the detection of causative agents of gastrointestinal (GI) tract infections.
North America is anticipated to account for the largest global gastrointestinal pathogen testing market share during the forecast period. The region, particularly the U.S. and Canada, boasts a highly advanced healthcare infrastructure with well-established healthcare systems, numerous hospitals, and a network of diagnostic laboratories. This infrastructure supports efficient and widespread access to gastrointestinal pathogen testing.
Prevalence of gastrointestinal infections is relatively high in North America. Factors such as population density, travel-related exposures, and lifestyle contribute to substantial demand for gastrointestinal pathogen testing. According to CDC estimates, each year around 1 in 6 persons in the U.S. (or 48 million people) gets sick, 128,000 are hospitalized, and 3,000 succumb to foodborne illnesses.
As per gastrointestinal pathogen testing market analysis, the industry in Asia Pacific is likely to expand at the fastest CAGR during the forecast period. The region experiences a significant burden of gastrointestinal infections due to factors such as population density, water and foodborne diseases, and environmental conditions. High prevalence of these infections increases the demand for diagnostic testing.
Asia Pacific is witnessing advancements in diagnostic technologies, including molecular testing methods and automation. Adoption of these technologies is contributing to the growth of the gastrointestinal pathogen testing market in the region. In 2021, around 1.33 million cases of infectious diarrhea were registered in China, making it the second-most common communicable disease after hand-foot-mouth disease in the country that year.
This report provides profiles of leading players operating in the global gastrointestinal pathogen testing market. These players engage in mergers & acquisitions, strategic collaborations, and new product launches to expand market presence.
bioMérieux SA, Becton, Dickinson, and Company (BD), QIAGEN, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Meridian Bioscience, Inc., Cepheid (Danaher Corporation), Laboratory Corporation of America Holdings, Illumina, Inc., DiaSorin S.p.A., Seegene, Inc., CerTest Biotec, S.L., Abbott, F. Hoffmann-La Roche Ltd., Genova Diagnostics, MicroGen DX, and Quidel Corporation are the prominent players in the global gastrointestinal pathogen testing market.
The gastrointestinal pathogen testing market report profiles the top players based on various factors such as a company overview, financial summary, strategies, product portfolio, segments, and recent advancements.
| Attribute | Detail |
|---|---|
| Size in 2022 | US$ 4.0 Bn |
| Forecast (Value) in 2031 | More than US$ 5.2 Bn |
| Growth Rate (CAGR) | 3.2% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional-level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 4.0 Bn in 2022
It is projected to reach more than US$ 5.2 Bn by 2031
The CAGR is anticipated to be 3.2% from 2023 to 2031
The molecular tests segment accounted for the largest share in 2022
North America is expected to account for the leading share during the forecast period.
bioMérieux SA, Becton, Dickinson, and Company (BD), QIAGEN, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Meridian Bioscience, Inc., Cepheid (Danaher Corporation), Laboratory Corporation of America Holdings, Illumina, Inc., DiaSorin S.p.A., Seegene, Inc., CerTest Biotec, S.L., Abbott, F. Hoffmann-La Roche Ltd., Genova Diagnostics, MicroGen DX, and Quidel Corporation.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Gastrointestinal Pathogen Testing Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Gastrointestinal Pathogen Testing Market Value Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Gastrointestinal Disorders: Overview
5.2. Technological Advancements
5.3. Key Industry Events (Key Developments, Partnership, Collaborations etc.)
5.4. Overview of the test type conducted across each of the End users
5.5. COVID-19 Pandemic Impact on Industry
6. Global Gastrointestinal Pathogen Testing Market Analysis, by Pathogen Type
6.1. Introduction
6.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Pathogen Type
6.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Pathogen Type
6.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Pathogen Type
6.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
6.5.1. Bacteria
6.5.1.1. Molecular Tests
6.5.1.2. Culture
6.5.1.3. Biochemical Tests
6.5.1.4. Others
6.5.2. Viruses
6.5.2.1. Molecular Tests
6.5.2.2. Culture
6.5.2.3. Others
6.5.3. Parasites
6.5.3.1. Ova and Parasite Microscopy
6.5.3.2. Molecular Tests
6.5.3.3. Others
7. Global Gastrointestinal Pathogen Testing Market Analysis, by Test Type
7.1. Introduction
7.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Test Type
7.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Test Type
7.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Test Type
7.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Test Type
7.5.1. Molecular Tests
7.5.2. Culture
7.5.3. Biochemical Tests
7.5.4. Others
8. Global Gastrointestinal Pathogen Testing Market Analysis, by Panel Type
8.1. Introduction
8.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Panel Type
8.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Panel Type
8.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Panel Type
8.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
8.5.1. Syndromic Full Multiplex Panels
8.5.2. Others
9. Global Gastrointestinal Pathogen Testing Market Analysis, by End-user
9.1. Introduction
9.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by End-user
9.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by End-user
9.4. Global Gastrointestinal Pathogen Testing Market Analysis, by End-user
9.5. Global Gastrointestinal Pathogen Testing Market Forecast, by End-user
9.5.1. Hospitals
9.5.1.1. Public
9.5.1.2. Private
9.5.1.3. Others
9.5.2. Diagnostic Laboratories
9.5.3. Point-of-Care
9.5.4. Others
10. Global Gastrointestinal Pathogen Testing Market Analysis, by Region
10.1. Introduction
10.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Region
10.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Region
10.4. Global Gastrointestinal Pathogen Testing Market Forecast, by Region
10.4.1. North America
10.4.2. Europe
10.4.3. Asia Pacific
10.4.4. Latin America
10.4.5. Middle East & Africa
11. North America Gastrointestinal Pathogen Testing Market Analysis
11.1. Key Insights: North America Gastrointestinal Pathogen Testing Market
11.2. North America Gastrointestinal Pathogen Testing Market Overview
11.3. North America Gastrointestinal Pathogen Testing Market Forecast, by Country
11.3.1. U.S.
11.3.2. Canada
11.4. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
11.5. North America Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
11.5.1. Bacteria
11.5.1.1. Molecular Tests
11.5.1.2. Culture
11.5.1.3. Biochemical Tests
11.5.1.4. Others
11.5.2. Viruses
11.5.2.1. Molecular Tests
11.5.2.2. Culture
11.5.2.3. Others
11.5.3. Parasites
11.5.3.1. Ova and Parasite Microscopy
11.5.3.2. Molecular Tests
11.5.3.3. Others
11.6. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
11.7. North America Gastrointestinal Pathogen Testing Market Forecast, by Test Type
11.7.1. Molecular Tests
11.7.2. Culture
11.7.3. Biochemical Tests
11.7.4. Others
11.8. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
11.9. North America Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
11.9.1. Syndromic Full Multiplex Panels
11.9.2. Others
11.10. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
11.11. North America Gastrointestinal Pathogen Testing Market Forecast, by End-user
11.11.1. Hospitals
11.11.1.1. Public
11.11.1.2. Private
11.11.1.3. Others
11.11.2. Diagnostic Laboratories
11.11.3. Point-of-Care
11.11.4. Others
12. Europe Gastrointestinal Pathogen Testing Market Analysis
12.1. Key Insights: Europe Gastrointestinal Pathogen Testing Market
12.2. Europe Gastrointestinal Pathogen Testing Market Overview
12.3. Europe Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
12.3.1. Germany
12.3.2. U.K.
12.3.3. France
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
12.4. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
12.5. Europe Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
12.5.1. Bacteria
12.5.1.1. Molecular Tests
12.5.1.2. Culture
12.5.1.3. Biochemical Tests
12.5.1.4. Others
12.5.2. Viruses
12.5.2.1. Molecular Tests
12.5.2.2. Culture
12.5.2.3. Others
12.5.3. Parasites
12.5.3.1. Ova and Parasite Microscopy
12.5.3.2. Molecular Tests
12.5.3.3. Others
12.6. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
12.7. Europe Gastrointestinal Pathogen Testing Market Forecast, by Test Type
12.7.1. Molecular Tests
12.7.2. Culture
12.7.3. Biochemical Tests
12.7.4. Others
12.8. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
12.9. Europe Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
12.9.1. Syndromic Full Multiplex Panels
12.9.2. Others
12.10. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
12.11. Europe Gastrointestinal Pathogen Testing Market Forecast, by End-user
12.11.1. Hospitals
12.11.1.1. Public
12.11.1.2. Private
12.11.1.3. Others
12.11.2. Diagnostic Laboratories
12.11.3. Point-of-Care
12.11.4. Others
13. Asia Pacific Gastrointestinal Pathogen Testing Market Analysis
13.1. Key Insights: Asia Pacific Gastrointestinal Pathogen Testing Market
13.2. Asia Pacific Gastrointestinal Pathogen Testing Market Overview
13.3. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
13.3.1. China
13.3.2. Japan
13.3.3. India
13.3.4. Australia & New Zealand
13.3.5. Rest of Asia Pacific
13.4. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
13.5. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
13.5.1. Bacteria
13.5.1.1. Molecular Tests
13.5.1.2. Culture
13.5.1.3. Biochemical Tests
13.5.1.4. Others
13.5.2. Viruses
13.5.2.1. Molecular Tests
13.5.2.2. Culture
13.5.2.3. Others
13.5.3. Parasites
13.5.3.1. Ova and Parasite Microscopy
13.5.3.2. Molecular Tests
13.5.3.3. Others
13.6. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
13.7. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Test Type
13.7.1. Molecular Tests
13.7.2. Culture
13.7.3. Biochemical Tests
13.7.4. Others
13.8. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
13.9. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
13.9.1. Syndromic Full Multiplex Panels
13.9.2. Others
13.10. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
13.11. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by End-user
13.11.1. Hospitals
13.11.1.1. Public
13.11.1.2. Private
13.11.1.3. Others
13.11.2. Diagnostic Laboratories
13.11.3. Point-of-Care
13.11.4. Others
14. Latin America Gastrointestinal Pathogen Testing Market Analysis
14.1. Key Insights: Latin America Gastrointestinal Pathogen Testing Market
14.2. Latin America Gastrointestinal Pathogen Testing Market Overview
14.3. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
14.3.1. Brazil
14.3.2. Mexico
14.3.3. Rest of Latin America
14.4. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
14.5. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
14.5.1. Bacteria
14.5.1.1. Molecular Tests
14.5.1.2. Culture
14.5.1.3. Biochemical Tests
14.5.1.4. Others
14.5.2. Viruses
14.5.2.1. Molecular Tests
14.5.2.2. Culture
14.5.2.3. Others
14.5.3. Parasites
14.5.3.1. Ova and Parasite Microscopy
14.5.3.2. Molecular Tests
14.5.3.3. Others
14.6. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
14.7. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Test Type
14.7.1. Molecular Tests
14.7.2. Culture
14.7.3. Biochemical Tests
14.7.4. Others
14.8. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
14.9. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
14.9.1. Syndromic Full Multiplex Panels
14.9.2. Others
14.10. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
14.11. Latin America Gastrointestinal Pathogen Testing Market Forecast, by End-user
14.11.1. Hospitals
14.11.1.1. Public
14.11.1.2. Private
14.11.1.3. Others
14.11.2. Diagnostic Laboratories
14.11.3. Point-of-Care
14.11.4. Others
15. Middle East & Africa Gastrointestinal Pathogen Testing Market Analysis
15.1. Key Insights: Middle East & Africa Gastrointestinal Pathogen Testing Market
15.2. Middle East & Africa Gastrointestinal Pathogen Testing Market Overview
15.3. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
15.3.1. GCC Countries
15.3.2. South Africa
15.3.3. Rest of Middle East & Africa
15.4. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
15.5. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
15.5.1. Bacteria
15.5.1.1. Molecular Tests
15.5.1.2. Culture
15.5.1.3. Biochemical Tests
15.5.1.4. Others
15.5.2. Viruses
15.5.2.1. Molecular Tests
15.5.2.2. Culture
15.5.2.3. Others
15.5.3. Parasites
15.5.3.1. Ova and Parasite Microscopy
15.5.3.2. Molecular Tests
15.5.3.3. Others
15.6. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
15.7. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Test Type
15.7.1. Molecular Tests
15.7.2. Culture
15.7.3. Biochemical Tests
15.7.4. Others
15.8. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
15.9. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
15.9.1. Syndromic Full Multiplex Panels
15.9.2. Others
15.10. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
15.11. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by End-user
15.11.1. Hospitals
15.11.1.1. Public
15.11.1.2. Private
15.11.1.3. Others
15.11.2. Diagnostic Laboratories
15.11.3. Point-of-Care
15.11.4. Others
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. bioMérieux SA
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Becton, Dickinson, and Company (BD)
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. QIAGEN
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Bio-Rad Laboratories, Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Thermo Fisher Scientific, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Meridian Bioscience, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Cepheid (Danaher Corporation)
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Laboratory Corporation of America Holdings
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Illumina, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. DiaSorin S.p.A.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Seegene, Inc.
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. CerTest Biotec, S.L.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. Abbott
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview
16.3.14. F. Hoffmann-La Roche Ltd.
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Product Portfolio
16.3.14.3. Financial Overview
16.3.14.4. SWOT Analysis
16.3.14.5. Strategic Overview
16.3.15. Genova Diagnostics
16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.15.2. Product Portfolio
16.3.15.3. Financial Overview
16.3.15.4. SWOT Analysis
16.3.15.5. Strategic Overview
16.3.16. MicroGen DX
16.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.16.2. Product Portfolio
16.3.16.3. Financial Overview
16.3.16.4. SWOT Analysis
16.3.16.5. Strategic Overview
16.3.17. Quidel Corporation
16.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.17.2. Product Portfolio
16.3.17.3. Financial Overview
16.3.17.4. SWOT Analysis
16.3.17.5. Strategic Overview
List of Tables
Table 01: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017-2031
Table 02: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Bacteria, 2017-2031
Table 03: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Viruses, 2017-2031
Table 04: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Parasites, 2017-2031
Table 05: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 06: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031
Table 07: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 08: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031
Table 09: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 10: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 11: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017-2031
Table 12: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Bacteria, 2017-2031
Table 13: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Viruses, 2017-2031
Table 14: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Parasites, 2017-2031
Table 15: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 16: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031
Table 17: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 18: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031
Table 19: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 20: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017-2031
Table 21: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Bacteria, 2017-2031
Table 22: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Viruses, 2017-2031
Table 23: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Parasites, 2017-2031
Table 24: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 25: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031
Table 26: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 27: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031
Table 28: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 29: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017-2031
Table 30: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Bacteria, 2017-2031
Table 31: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Viruses, 2017-2031
Table 32: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Parasites, 2017-2031
Table 33: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 34: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031
Table 35: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 36: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031
Table 37: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 38: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017-2031
Table 39: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Bacteria, 2017-2031
Table 40: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Viruses, 2017-2031
Table 41: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Parasites, 2017-2031
Table 42: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 43: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031
Table 44: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 45: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031
Table 46: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 47: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017-2031
Table 48: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Bacteria, 2017-2031
Table 49: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Viruses, 2017-2031
Table 50: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Parasites, 2017-2031
Table 51: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 52: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031
Table 53: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 54: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031
List of Figures
Figure 01: Global Gastrointestinal Pathogen Testing Market Size, by Pathogen Type, 2022
Figure 02: Gastrointestinal Pathogen Testing Market Share (%), by Pathogen Type, 2022
Figure 03: Global Gastrointestinal Pathogen Testing Market Size, by Test Type, 2022
Figure 04: Gastrointestinal Pathogen Testing Market Share (%), by Test Type, 2022
Figure 05: Global Gastrointestinal Pathogen Testing Market Size, by Panel Type, 2022
Figure 06: Gastrointestinal Pathogen Testing Market Share (%), by Panel Type, 2022
Figure 07: Global Gastrointestinal Pathogen Testing Market Size, by End-user, 2022
Figure 08: Gastrointestinal Pathogen Testing Market Share (%), by End-user, 2022
Figure 09: Global Gastrointestinal Pathogen Testing Market, by Region (2022 and 2031)
Figure 10: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, 2017–2031
Figure 11: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022 and 2031
Figure 12: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022
Figure 13: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2031
Figure 14: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Pathogen Type, 2023–2031
Figure 15: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Bacteria, 2017‒2031
Figure 16: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Bacteria, 2022 and 2031
Figure 17: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Viruses, 2017‒2031
Figure 18: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Viruses, 2022 and 2031
Figure 19: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Parasites, 2017‒2031
Figure 20: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Parasites, 2022 and 2031
Figure 21: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Bacteria Pathogen Test, 2023–2031
Figure 22: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Viruses Pathogen Test, 2023–2031
Figure 23: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Parasite Pathogen Test, 2023–2031
Figure 24: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
Figure 25: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022
Figure 26: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2031
Figure 27: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Test Type, 2023–2031
Figure 28: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Molecular Tests, 2017‒2031
Figure 29: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Molecular Tests, 2022 and 2031
Figure 30: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Culture, 2017‒2031
Figure 31: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Culture, 2022 and 2031
Figure 32: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Biochemical Tests, 2017‒2031
Figure 33: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Biochemical Tests, 2022 and 2031
Figure 34: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Culture, 2017‒2031
Figure 35: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Culture, 2022 and 2031
Figure 36: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022 and 2031
Figure 37: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022
Figure 38: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2031
Figure 39: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Panel Type, 2023–2031
Figure 40: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Syndromic Full Multiplex Panels, 2017‒2031
Figure 41: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Syndromic Full Multiplex Panels, 2022 and 2031
Figure 42: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Others, 2017‒2031
Figure 43: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Others, 2022 and 2031
Figure 44: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 45: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022
Figure 46: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2031
Figure 47: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 48: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Hospitals, 2017‒2031
Figure 49: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Hospitals, 2022 and 2031
Figure 50: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Others, 2017‒2031
Figure 51: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Diagnostic Laboratories, 2022 and 2031
Figure 52: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Point-of-Care, 2017‒2031
Figure 53: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Point-of-Care, 2022 and 2031
Figure 54: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Others, 2017‒2031
Figure 55: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Others, 2022 and 2031
Figure 56: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Region, 2022 and 2031
Figure 57: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Region, 2022
Figure 58: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Region, 2031
Figure 59: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Region, 2023–2031
Figure 60: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 61: North America Gastrointestinal Pathogen Testing Market Value Share Analysis, by Country, 2022 and 2031
Figure 62: North America Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Country, 2023–2031
Figure 63: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022 and 2031
Figure 64: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022
Figure 65: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
Figure 66: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022
Figure 67: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022 and 2031
Figure 68: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022
Figure 69: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 70: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022
Figure 71: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 72: Europe Gastrointestinal Pathogen Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 73: Europe Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 74: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022 and 2031
Figure 75: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022
Figure 76: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
Figure 77: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022
Figure 78: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022 and 2031
Figure 79: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022
Figure 80: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 81: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022
Figure 82: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 83: Asia Pacific Gastrointestinal Pathogen Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 84: Asia Pacific Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 85: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022 and 2031
Figure 86: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022
Figure 87: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
Figure 88: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022
Figure 89: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022 and 2031
Figure 90: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022
Figure 91: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 92: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022
Figure 93: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 94: Latin America Gastrointestinal Pathogen Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 95: Latin America Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 96: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022 and 2031
Figure 97: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022
Figure 98: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
Figure 99: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022
Figure 100: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022 and 2031
Figure 101: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022
Figure 102: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 103: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022
Figure 104: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 105: Middle East & Africa Gastrointestinal Pathogen Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 106: Middle East & Africa Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 107: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022 and 2031
Figure 108: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022
Figure 109: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031
Figure 110: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022
Figure 111: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022 and 2031
Figure 112: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022
Figure 113: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 114: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Gastrointestinal Pathogen Testing Market
*86 figures and 60 tables includes